The Characterisation of Pax3 Expressant Cells in Adult Peripheral Nerve

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Blake, Judith A ^a   Ziman, Melanie R ^a,b  

^a EDITH COWAN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR PAX3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL LINEAGE; CELL STRUCTURE; CELL SUBPOPULATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PERIPHERAL NERVE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RNA TRANSCRIPTION; SCHWANN CELL; SCIATIC NERVE;

ANIMALS; DNA PRIMERS; EARLY GROWTH RESPONSE PROTEIN 1; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PAIRED BOX TRANSCRIPTION FACTORS; PHENOTYPE; RECEPTOR, NERVE GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHWANN CELLS; SCIATIC NERVE;

EID: 84875102453     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059184     Document Type: Article

References (81)

1. Epstein DJ, Malo D, Vekemans M, Gros P, (1991) Molecular characterization of a deletion encompassing the splotch mutation on mouse chromosome 1. Genomics 10: 89-93.
2. Tassabehji M, Read AP, Newton VE, Harris R, Balling R, et al. (1992) Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 355: 635-636.
3. Xia SJ, Barr FG, (2004) Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein. Oncogene 23: 6864-6871.
4. Keller C, Arenkiel BR, Coffin CM, El-Bardeesy N, DePinho RA, et al. (2004) Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev 18: 2614-2626.
5. Relaix F, Rocancourt D, Mansouri A, Buckingham M, (2005) A Pax3/Pax7-dependent population of skeletal muscle progenitor cells. Nature 435: 948-953.
6. Lang D, Lu MM, Huang L, Engleka KA, Zhang M, et al. (2005) Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433: 884-887.
7. Osawa M, Egawa G, Mak SS, Moriyama M, Freter R, et al. (2005) Molecular characterization of melanocyte stem cells in their niche. Development 132: 5589-5599.
8. Relaix F, Montarras D, Zaffran S, Gayraud-Morel B, Rocancourt D, et al. (2006) Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. J Cell Biol 172: 91-102.
9. Blake JA, Thomas M, Thompson JA, White R, Ziman M, (2008) Perplexing Pax: from puzzle to paradigm. Dev Dyn 237: 2791-2803.
10. Crist CG, Montarras D, Pallafacchina G, Rocancourt D, Cumano A, et al. (2009) Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proc Natl Acad Sci U S A 106: 13383-13387.
11. Lepper C, Conway SJ, Fan CM, (2009) Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements. Nature 460: 627-631.
12. Medic S, Ziman M, (2010) PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas). PLoS One 5: e9977.
13. Reeves FC, Burdge GC, Fredericks WJ, Rauscher FJ, Lillycrop KA, (1999) Induction of antisense Pax-3 expression leads to the rapid morphological differentiation of neuronal cells and an altered response to the mitogenic growth factor bFGF. J Cell Sci 112 (Pt 2): 253-261.
14. Kioussi C, Gross MK, Gruss P, (1995) Pax3: a paired domain gene as a regulator in PNS myelination. Neuron 15: 553-562.
15. Padilla F, Marc Mege R, Sobel A, Nicolet M, (1999) Upregulation and redistribution of cadherins reveal specific glial and muscle cell phenotypes during wallerian degeneration and muscle denervation in the mouse. J Neurosci Res 58: 270-283.
16. Gershon TR, Oppenheimer O, Chin SS, Gerald WL, (2005) Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation. Neoplasia 7: 575-584.
17. Barber TD, Barber MC, Cloutier TE, Friedman TB, (1999) PAX3 gene structure, alternative splicing and evolution. Gene 237: 311-319.
18. Pritchard C, Grosveld G, Hollenbach AD, (2003) Alternative splicing of Pax3 produces a transcriptionally inactive protein. Gene 305: 61-69.
19. Tsukamoto K, Nakamura Y, Niikawa N, (1994) Isolation of two isoforms of the PAX3 gene transcripts and their tissue-specific alternative expression in human adult tissues. Hum Genet 93: 270-274.
20. Goulding MD, Chalepakis G, Deutsch U, Erselius JR, Gruss P, (1991) Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. Embo J 10: 1135-1147.
21. Carlsen F, Behse F, (1980) Three dimensional analysis of Schwann cells associated with unmyelinated nerve fibres in human sural nerve. J Anat 130: 545-557.
22. Murinson BB, Hoffman PN, Banihashemi MR, Meyer RA, Griffin JW, (2005) C-fiber (Remak) bundles contain both isolectin B4-binding and calcitonin gene-related peptide-positive axons. J Comp Neurol 484: 392-402.
23. Guenard V, Montag D, Schachner M, Martini R, (1996) Onion bulb cells in mice deficient for myelin genes share molecular properties with immature, differentiated non-myelinating, and denervated Schwann cells. Glia 18: 27-38.
24. Venters SJ, Argent RE, Deegan FM, Perez-Baron G, Wong TS, et al. (2004) Precocious terminal differentiation of premigratory limb muscle precursor cells requires positive signalling. Dev Dyn 229: 591-599.
25. Kury P, Greiner-Petter R, Cornely C, Jurgens T, Muller HW, (2002) Mammalian achaete scute homolog 2 is expressed in the adult sciatic nerve and regulates the expression of Krox24, Mob-1, CXCR4, and p57kip2 in Schwann cells. J Neurosci 22: 7586-7595.
26. Topilko P, Levi G, Merlo G, Mantero S, Desmarquet C, et al. (1997) Differential regulation of the zinc finger genes Krox-20 and Krox-24 (Egr-1) suggests antagonistic roles in Schwann cells. J Neurosci Res 50: 702-712.
27. Le N, Nagarajan R, Wang JY, Araki T, Schmidt RE, et al. (2005) Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci U S A 102: 2596-2601.
28. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, et al. (1994) Krox-20 controls myelination in the peripheral nervous system. Nature 371: 796-799.
29. Murphy P, Topilko P, Schneider-Maunoury S, Seitanidou T, Baron-Van Evercooren A, et al. (1996) The regulation of Krox-20 expression reveals important steps in the control of peripheral glial cell development. Development 122: 2847-2857.
30. Garratt AN, Voiculescu O, Topilko P, Charnay P, Birchmeier C, (2000) A dual role of erbB2 in myelination and in expansion of the schwann cell precursor pool. J Cell Biol 148: 1035-1046.
31. Gnocchi VF, White RB, Ono Y, Ellis JA, Zammit PS, (2009) Further characterisation of the molecular signature of quiescent and activated mouse muscle satellite cells. PLoS One 4: e5205.
32. Adameyko I, Lallemend F, Furlan A, Zinin N, Aranda S, et al. (2012) Sox2 and Mitf cross-regulatory interactions consolidate progenitor and melanocyte lineages in the cranial neural crest. Development 139: 397-410.
33. Fernandes KJ, Toma JG, Miller FD, (2008) Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential. Philos Trans R Soc Lond B Biol Sci 363: 185-198.
34. Kruger GM, Mosher JT, Bixby S, Joseph N, Iwashita T, et al. (2002) Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron 35: 657-669.
35. Li L, Fukunaga-Kalabis M, Yu H, Xu X, Kong J, et al. (2010) Human dermal stem cells differentiate into functional epidermal melanocytes. J Cell Sci 123: 853-860.
36. Wakamatsu Y, Endo Y, Osumi N, Weston JA, (2004) Multiple roles of Sox2, an HMG-box transcription factor in avian neural crest development. Dev Dyn 229: 74-86.
37. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
38. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, et al. (2007) Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9: 625-635.
39. Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, et al. (2011) Generation of human melanocytes from induced pluripotent stem cells. PLoS One 6: e16182.
40. Wong CE, Paratore C, Dours-Zimmermann MT, Rochat A, Pietri T, et al. (2006) Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin. J Cell Biol 175: 1005-1015.
41. Sobue G, (1990) [The role of Schwann cells in peripheral nerve degeneration and regeneration-NGF-NGF receptor system]. Rinsho Shinkeigaku 30: 1358-1360.
42. Davids LM, du Toit E, Kidson SH, Todd G, (2009) A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem-cell reservoir of melanocytes? Clin Exp Dermatol 34: 246-248.
43. Cramer SF, (2009) Stem cells for epidermal melanocytes-a challenge for students of dermatopathology. Am J Dermatopathol 31: 331-341.
44. Jessen KR, Mirsky R, (1992) Schwann cells: early lineage, regulation of proliferation and control of myelin formation. Curr Opin Neurobiol 2: 575-581.
45. Jessen KR, Mirsky R (1994) Neural development. Fate diverted. Curr Biol 4, 824-827.
46. Dong Z, Sinanan A, Parkinson D, Parmantier E, Mirsky R, et al. (1999) Schwann cell development in embryonic mouse nerves. J Neurosci Res 56: 334-348.
47. Grinspan JB, Marchionni MA, Reeves M, Coulaloglou M, Scherer SS, (1996) Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 16: 6107-6118.
48. Syroid DE, Maycox PR, Burrola PG, Liu N, Wen D, et al. (1996) Cell death in the Schwann cell lineage and its regulation by neuregulin. Proc Natl Acad Sci U S A 93: 9229-9234.
49. Dong Z, Brennan A, Liu N, Yarden Y, Lefkowitz G, et al. (1995) Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors. Neuron 15: 585-596.
50. Meier C, Parmantier E, Brennan A, Mirsky R, Jessen KR, (1999) Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB. J Neurosci 19: 3847-3859.
51. Chen S, Rio C, Ji RR, Dikkes P, Coggeshall RE, et al. (2003) Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nat Neurosci 6: 1186-1193.
52. Salzer JL, Bunge RP, (1980) Studies of Schwann cell proliferation. I. An analysis in tissue culture of proliferation during development, Wallerian degeneration, and direct injury. J Cell Biol 84: 739-752.
53. Stoll G, Griffin JW, Li CY, Trapp BD, (1989) Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol 18: 671-683.
54. Griffin JW, Thompson WJ, (2008) Biology and pathology of nonmyelinating Schwann cells. Glia 56: 1518-1531.
55. Weinberg HJ, Spencer PS, (1978) The fate of Schwann cells isolated from axonal contact. J Neurocytol 7: 555-569.
56. Perry VH, Brown MC, (1992) Role of macrophages in peripheral nerve degeneration and repair. Bioessays 14: 401-406.
57. Fernandez-Valle C, Bunge RP, Bunge MB, (1995) Schwann cells degrade myelin and proliferate in the absence of macrophages: evidence from in vitro studies of Wallerian degeneration. J Neurocytol 24: 667-679.
58. Stoll G, Muller HW, (1999) Nerve injury, axonal degeneration and neural regeneration: basic insights. Brain Pathol 9: 313-325.
59. Gupta SK, Poduslo JF, Dunn R, Roder J, Mezei C, (1990) Myelin-associated glycoprotein gene expression in the presence and absence of Schwann cell-axonal contact. Dev Neurosci 12: 22-33.
60. LeBlanc AC, Poduslo JF, (1990) Axonal modulation of myelin gene expression in the peripheral nerve. J Neurosci Res 26: 317-326.
61. Spreyer P, Schaal H, Kuhn G, Rothe T, Unterbeck A, et al. (1990) Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. Embo J 9: 2479-2484.
62. Scherer SS, Xu YT, Bannerman PG, Sherman DL, Brophy PJ, (1995) Periaxin expression in myelinating Schwann cells: modulation by axon-glial interactions and polarized localization during development. Development 121: 4265-4273.
63. Pellegrino RG, Politis MJ, Ritchie JM, Spencer PS, (1986) Events in degenerating cat peripheral nerve: induction of Schwann cell S phase and its relation to nerve fibre degeneration. J Neurocytol 15: 17-28.
64. Baichwal RR, DeVries GH, (1989) A mitogen for Schwann cells is derived from myelin basic protein. Biochem Biophys Res Commun 164: 883-888.
65. Ide C, Tohyama K, Yokota R, Nitatori T, Onodera S, (1983) Schwann cell basal lamina and nerve regeneration. Brain Res 288: 61-75.
66. Salonen V, Peltonen J, Roytta M, Virtanen I, (1987) Laminin in traumatized peripheral nerve: basement membrane changes during degeneration and regeneration. J Neurocytol 16: 713-720.
67. Tona A, Perides G, Rahemtulla F, Dahl D, (1993) Extracellular matrix in regenerating rat sciatic nerve: a comparative study on the localization of laminin, hyaluronic acid, and chondroitin sulfate proteoglycans, including versican. J Histochem Cytochem 41: 593-599.
68. Ara J, Bannerman P, Shaheen F, Pleasure DE, (2005) Schwann cell-autonomous role of neuropilin-2. J Neurosci Res 79: 468-475.
69. Griffin JW, Drucker N, Gold BG, Rosenfeld J, Benzaquen M, et al. (1987) Schwann cell proliferation and migration during paranodal demyelination. J Neurosci 7: 682-699.
70. Gutmann DH, Hirbe AC, Haipek CA, (2001) Functional analysis of neurofibromatosis 2 (NF2) missense mutations. Hum Mol Genet 10: 1519-1529.
71. Theos A, Korf BR, (2006) Pathophysiology of neurofibromatosis type 1. Ann Intern Med 144: 842-849.
72. Cichowski K, Jacks T, (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104: 593-604.
73. Riccardi VM, (2000) Histogenesis control genes: embryology, wound-healing, and NF1. Teratology 62: 4.
74. Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF, (2002) Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296: 920-922.
75. Serra E, Rosenbaum T, Winner U, Aledo R, Ars E, et al. (2000) Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum Mol Genet 9: 3055-3064.
76. Rutkowski JL, Wu K, Gutmann DH, Boyer PJ, Legius E, (2000) Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet 9: 1059-1066.
77. Sheela S, Riccardi VM, Ratner N, (1990) Angiogenic and invasive properties of neurofibroma Schwann cells. J Cell Biol 111: 645-653.
78. Zheng H, Chang L, Patel N, Yang J, Lowe L, et al. (2008) Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation. Cancer Cell 13: 117-128.
79. Pongpudpunth M, Bhawan J, Al-Natour SH, Mahalingam M, (2010) Nestin-positive stem cells in neurofibromas from patients with neurofibromatosis type 1-tumorigenic or incidental? Am J Dermatopathol 32: 574-577.
80. Djian-Zaouche J, Campagne C, Reyes-Gomez E, Gadin-Czerw S, Bernex F, et al. (2012) Pax3(GFP), a new reporter for the melanocyte lineage, highlights novel aspects of PAX3 expression in the skin. Pigment Cell Melanoma Res 25: 545-554.
81. Botchkarev VA, Eichmuller S, Johansson O, Paus R, (1997) Hair cycle-dependent plasticity of skin and hair follicle innervation in normal murine skin. J Comp Neurol 386: 379-395.